AxoSim

AxoSim

Biotechnology Research

New Orleans, LA 2,590 followers

Human Data, Faster.

About us

AxoSim empowers advancements in human neuroscience by partnering with biopharma companies to facilitate breakthroughs in devastating neurological diseases and disorders. Their proprietary drug discovery platforms NerveSim®, BrainSim®, and microBrain™ deliver clinically-relevant data to select better lead candidates with phenotypically accurate assays. AxoSim's platforms have applications in peripheral neuropathy and neuropathic pain, disease modeling (such as ALS, MS, and CMT), and neurotoxicology. Is your organization interested in learning more about what we do? Please email us at info@axosim.com.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
New Orleans, LA
Type
Privately Held
Founded
2014
Specialties
Drug Developent, Preclinical Testing, Neurotoxicity, Neuroefficacy, 3D Cell Assays, Neurodegenerative Disease Models, Myelination Models, Nerve-on-a-Chip, Organ-on-a-Chip, Peripheral Neuropathy, Toxicology, Neuroscience, and organoids

Locations

Employees at AxoSim

Updates

Similar pages

Browse jobs

Funding

AxoSim 13 total rounds

Last Round

Series unknown

US$ 6.1M

See more info on crunchbase